Outlook Therapeutics (formerly known as Oncobiologics) is a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics. Its current focus is on monoclonal antibodies in the disease areas of immunology and oncology.